CD8A and cancer: Data presented here point to an additional mechanism in which an Ad vector designed to induce FAP+ cell-depleting CD8+T cells combined with a traditional cancer vaccine changes the immune balances within the TME by reducing levels of immunosuppression while enhancing functions of MAA-specific CD8+T cells through reducing their metabolic stress.